Orchard Therapeutics Statistics
Total Valuation
PR has a market cap or net worth of $10.64 billion. The enterprise value is $14.21 billion.
| Market Cap | 10.64B |
| Enterprise Value | 14.21B |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Sep 16, 2025 |
Share Statistics
PR has 795.46 million shares outstanding. The number of shares has increased by 40.55% in one year.
| Current Share Class | 697.76M |
| Shares Outstanding | 795.46M |
| Shares Change (YoY) | +40.55% |
| Shares Change (QoQ) | -0.29% |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 97.46% |
| Float | 648.32M |
Valuation Ratios
The trailing PE ratio is 8.71 and the forward PE ratio is 11.09.
| PE Ratio | 8.71 |
| Forward PE | 11.09 |
| PS Ratio | 1.79 |
| Forward PS | 1.98 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 1.11 |
| P/FCF Ratio | 37.05 |
| P/OCF Ratio | 2.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.66, with an EV/FCF ratio of 50.16.
| EV / Earnings | 12.47 |
| EV / Sales | 2.79 |
| EV / EBITDA | 3.66 |
| EV / EBIT | 7.27 |
| EV / FCF | 50.16 |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.38.
| Current Ratio | 0.63 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 0.98 |
| Debt / FCF | 14.70 |
| Interest Coverage | 6.32 |
Financial Efficiency
Return on equity (ROE) is 13.11% and return on invested capital (ROIC) is 8.50%.
| Return on Equity (ROE) | 13.11% |
| Return on Assets (ROA) | 7.43% |
| Return on Invested Capital (ROIC) | 8.50% |
| Return on Capital Employed (ROCE) | 12.48% |
| Revenue Per Employee | $10.55M |
| Profits Per Employee | $2.36M |
| Employee Count | 482 |
| Asset Turnover | 0.31 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PR has paid $331.93 million in taxes.
| Income Tax | 331.93M |
| Effective Tax Rate | 19.76% |
Stock Price Statistics
The stock price has decreased by -8.56% in the last 52 weeks. The beta is 1.31, so PR's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -8.56% |
| 50-Day Moving Average | 13.84 |
| 200-Day Moving Average | 13.85 |
| Relative Strength Index (RSI) | 44.81 |
| Average Volume (20 Days) | 10,544,042 |
Short Selling Information
The latest short interest is 43.39 million, so 5.46% of the outstanding shares have been sold short.
| Short Interest | 43.39M |
| Short Previous Month | 47.05M |
| Short % of Shares Out | 5.46% |
| Short % of Float | 6.69% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, PR had revenue of $5.09 billion and earned $1.14 billion in profits. Earnings per share was $1.54.
| Revenue | 5.09B |
| Gross Profit | 3.77B |
| Operating Income | 1.95B |
| Pretax Income | n/a |
| Net Income | 1.14B |
| EBITDA | 3.88B |
| EBIT | 1.95B |
| Earnings Per Share (EPS) | $1.54 |
Balance Sheet
The company has $451.00 million in cash and $4.16 billion in debt, giving a net cash position of -$3.71 billion or -$4.67 per share.
| Cash & Cash Equivalents | 451.00M |
| Total Debt | 4.16B |
| Net Cash | -3.71B |
| Net Cash Per Share | -$4.67 |
| Equity (Book Value) | 10.90B |
| Book Value Per Share | 13.49 |
| Working Capital | -679.88M |
Cash Flow
In the last 12 months, operating cash flow was $3.76 billion and capital expenditures -$3.48 billion, giving a free cash flow of $283.26 million.
| Operating Cash Flow | 3.76B |
| Capital Expenditures | -3.48B |
| Free Cash Flow | 283.26M |
| FCF Per Share | $0.36 |
Margins
Gross margin is 74.06%, with operating and profit margins of 38.43% and 22.41%.
| Gross Margin | 74.06% |
| Operating Margin | 38.43% |
| Pretax Margin | 33.02% |
| Profit Margin | 22.41% |
| EBITDA Margin | 76.37% |
| EBIT Margin | 38.43% |
| FCF Margin | 5.57% |
Dividends & Yields
This stock pays an annual dividend of $0.60, which amounts to a dividend yield of 4.48%.
| Dividend Per Share | $0.60 |
| Dividend Yield | 4.48% |
| Dividend Growth (YoY) | -11.76% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 39.06% |
| Buyback Yield | -40.54% |
| Shareholder Yield | -36.00% |
| Earnings Yield | 10.86% |
| FCF Yield | 2.70% |
Analyst Forecast
The average price target for PR is $18.43, which is 37.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.43 |
| Price Target Difference | 37.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PR has an Altman Z-Score of 1.62 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.62 |
| Piotroski F-Score | 6 |